Chi-Jung Chung

Dr. Chi-Jung Chung

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2013 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
CCChia‐Wen Chen
Chia‐Wen Chen
CLChe‐Chen Lin
Che‐Chen Lin
KCKuen-Bao Chen
Kuen-Bao Chen
YKYu‐Cheng Kuo
Yu‐Cheng Kuo
CLChi-Yuan Li
Chi-Yuan Li
CCChi-Jung Chung
Chi-Jung Chung

1 December 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
FCFen Chu-Ko
Fen Chu-Ko
MCMeng-Ling Chong
Meng-Ling Chong
CCChi-Jung Chung
Chi-Jung Chung
CCChun-Chi Chang
Chun-Chi Chang
HLHsin-Yi Liu
Hsin-Yi Liu
LHLi-Chi Huang
Li-Chi Huang
Background: Health literacy has been concerned a key factor for determining the use of health information and promoting health. The study aimed to explore adolescent health literacy, health-promoting lifestyle profile, and health status and related factors. Methods: A cross-sectional study design was used; 918 first year junior college students were recruited in Taiwan. The measurements were the Chinese Health Literacy Survey Questionnaire (HLS-C-Q), the Chinese Health-Promoting Lifestyle Profile (HPLP-S), and the Health Status Questionnaire. Results: The mean score for health literacy was 36.15 (±6.21), with 30.17% of the participants having insufficient or problematic health literacy. Further, 19.9% of participants were obese and 11.2% experienced emotional instability. Health literacy and health-promoting lifestyle profile showed significant positive and negative correlations with perceived health status and depression, respectively (p < 0.05). An exercise frequency of ≥3 times/week was a predictor of health literacy, health-promoting lifestyle profile, and emotional stability. Conclusions: Adolescent health literacy, health-promoting lifestyle profile, and health status require careful consideration. In adolescents, developing regular exercise may increase health literacy, thereby developing healthy lifestyle profiles and ameliorating obesity and depression-related issues.

1 August 2019 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
CWChih-Yin Wu
Chih-Yin Wu
CWChung-Shun Wong
Chung-Shun Wong
CCChi-Jung Chung
Chi-Jung Chung
MWMei-Yi Wu
Mei-Yi Wu
YHYa-Li Huang
Ya-Li Huang
YHYu-Mei Hsueh
Yu-Mei Hsueh

Verified
Journal Article
Open access
PDF file
YKYing-Yu Kuo
Ying-Yu Kuo
WJWai-Tim Jim
Wai-Tim Jim
LSLiang-Cheng Su
Liang-Cheng Su
CCChi-Jung Chung
Chi-Jung Chung
CLChing-Yu Lin
Ching-Yu Lin
CCChih-Pin Chuu
Chih-Pin Chuu
Head and neck cancers, which affect 650,000 people and cause 350,000 deaths per year, is the sixth leading cancer by cancer incidence and eighth by cancer-related death worldwide. Oral cancer is the most common type of head and neck cancer. More than 90% of oral cancers are oral and oropharyngeal squamous cell carcinoma (OSCC). The overall five-year survival rate of OSCC patients is approximately 63%, which is due to the low response rate to current therapeutic drugs. In this review we discuss the possibility of using caffeic acid phenethyl ester (CAPE) as an alternative treatment for oral cancer. CAPE is a strong antioxidant extracted from honeybee hive propolis. Recent studies indicate that CAPE treatment can effectively suppress the proliferation, survival, and metastasis of oral cancer cells. CAPE treatment inhibits Akt signaling, cell cycle regulatory proteins, NF-κB function, as well as activity of matrix metalloproteinase (MMPs), epidermal growth factor receptor (EGFR), and Cyclooxygenase-2 (COX-2). Therefore, CAPE treatment induces cell cycle arrest and apoptosis in oral cancer cells. According to the evidence that aberrations in the EGFR/phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling, NF-κB function, COX-2 activity, and MMPs activity are frequently found in oral cancers, and that the phosphorylation of Akt, EGFR, and COX-2 correlates to oral cancer patient survival and clinical progression, we believe that CAPE treatment will be useful for treatment of advanced oral cancer patients.

1 October 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YYYu-Wan Yang
Yu-Wan Yang
SLSaou-Hsing Liou
Saou-Hsing Liou
YHYu-Mei Hsueh
Yu-Mei Hsueh
WLWun-Sin Lyu
Wun-Sin Lyu
CLChiu-Shong Liu
Chiu-Shong Liu
CCChi-Jung Chung
Chi-Jung Chung

Verified
Journal Article
Open access
PDF file
JCJang Yang Chang
Jang Yang Chang
JCJang Yang Chang
Jang Yang Chang
JCJang Yang Chang
Jang Yang Chang
JCJang Yang Chang
Jang Yang Chang
JYJonathan Yang
Jonathan Yang
CCChih-Pin Chuu
Chih-Pin Chuu
Caffeic acid phenethyl ester (CAPE) is a bioactive component extracted from honeybee hive propolis. Our observations indicated that CAPE treatment suppressed cell proliferation and colony formation of TW2.6 human oral squamous cell carcinoma (OSCC) cells dose-dependently. CAPE treatment decreased G1 phase cell population, increased G2/M phase cell population, and induced apoptosis in TW2.6 cells. Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip. Overexpression of Akt1 or Akt2 in TW2.6 cells rescued growth inhibition caused by CAPE treatment. Co-treating TW2.6 cells with CAPE and 5-fluorouracil, a commonly used chemotherapeutic drug for oral cancers, exhibited additive cell proliferation inhibition. Our study suggested that administration of CAPE is a potential adjuvant therapy for patients with OSCC oral cancer.